LS or CMMRD caused by hypomorphic variants should be considered when a cancer patient has a family history of LS-associated cancers and/or has been found to have germline mono- or bi-allelic MMR VUS, even if the tumour retains MMR protein expression or is MSS. This evidence concerns the gene MRC1 and cancer.